论文部分内容阅读
目的:探究慢性前列腺炎采用美洛昔康治疗的临床应用效果。方法:选取2013年6月至2014年12月在我院治疗的慢性前列腺炎患者88例,按照随机分组原则将患者分为对照组和治疗组分别44例,对照组患者采取常规对症缓解治疗,治疗组患者则在常规对症治疗的同时结合美洛昔康治疗,对比两组患者的临床治疗效果。结果:治疗组慢性前列腺炎患者的临床治疗有效率为93.2%,对照组慢性前列腺炎患者的临床治疗有效率为61.4%,治疗组临床治疗效果明显优于对照组,差异显著具有统计意义(P<0.05)。结论:在慢性前列腺炎的临床治疗中应用美洛昔康治疗能够显著改善患者的治疗效果,有利于优化患者生活质量,值得在临床上推广应用。
Objective: To investigate the clinical application of meloxicam in the treatment of chronic prostatitis. Methods: Seventy eight patients with chronic prostatitis treated in our hospital from June 2013 to December 2014 were divided into control group and treatment group according to the principle of randomization. Forty-four patients in control group were treated with conventional symptomatic treatment, Patients in the treatment group were treated with meloxicam in combination with conventional symptomatic treatment, and the clinical effects of the two groups were compared. Results: The effective rate of clinical treatment in patients with chronic prostatitis was 93.2% in the treatment group and 61.4% in the control group. The clinical effect of the treatment group was significantly better than that of the control group (P <0.05). Conclusion: The application of meloxicam in the clinical treatment of chronic prostatitis can significantly improve the therapeutic effect of patients, which is beneficial to optimize the quality of life of patients and is worth popularizing in clinic.